113 related articles for article (PubMed ID: 7266020)
1. Thymidine enhancement of 1-beta-d-arabinofuranosylcytosine activity for mouse EL4 tumors.
Reiter H
Leuk Res; 1981; 5(3):259-63. PubMed ID: 7266020
[No Abstract] [Full Text] [Related]
2. Effect of thymidine on the survival of mice with EL4 tumors.
Reiter H
Cancer Res; 1979 Dec; 39(12):4856-60. PubMed ID: 498113
[No Abstract] [Full Text] [Related]
3. Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine.
Harris AW; Reynolds EC; Finch LR
Cancer Res; 1979 Feb; 39(2 Pt 1):538-41. PubMed ID: 761229
[TBL] [Abstract][Full Text] [Related]
4. Effect of thymidine on the toxicity, antitumor activity, and metabolism of 1-beta-D-arabinofuranosylcytosine in rats bearing a chemically induced colon carcinoma.
Danhauser LL; Rustum YM
Cancer Res; 1980 Apr; 40(4):1274-80. PubMed ID: 7357557
[No Abstract] [Full Text] [Related]
5. Role of thymidine in biochemical modulation: a review.
O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B
Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and antitumor effects of the combination of thymidine and 1-beta-D-arabinofuranosylcytosine against leukemia L1210.
Kinahan JJ; Kowal EP; Grindey GB
Cancer Res; 1981 Feb; 41(2):445-51. PubMed ID: 7448789
[No Abstract] [Full Text] [Related]
7. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y
Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
Grant S; Lehman C; Cadman E
Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
[No Abstract] [Full Text] [Related]
9. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
Gibson MH; Bertalanffy FD
J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
[No Abstract] [Full Text] [Related]
10. Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H
Adv Exp Med Biol; 1989; 253B():349-54. PubMed ID: 2610122
[No Abstract] [Full Text] [Related]
11. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
Edelstein M; Vietti T; Valeriote F
Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
[No Abstract] [Full Text] [Related]
12. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
Dollinger MR; Burchenal JH; Kreis W; Fox JJ
Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
[No Abstract] [Full Text] [Related]
13. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.
Streifel JA; Howell SB
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5132-6. PubMed ID: 6975478
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
Harkrader RJ; Boritzki TJ; Jackson RC
Biochem Pharmacol; 1981 May; 30(10):1099-104. PubMed ID: 6973342
[No Abstract] [Full Text] [Related]
15. Effect of cysteine on the survival of mice with transplanted malignant thymoma.
Campbell NR; Reade PC; Radden BG
Nature; 1974 Sep; 251(5471):158-9. PubMed ID: 4370766
[No Abstract] [Full Text] [Related]
16. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.
Graham FL; Whitmore GF
Cancer Res; 1970 Nov; 30(11):2627-35. PubMed ID: 5530557
[No Abstract] [Full Text] [Related]
17. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
Danhauser LL; Rustum YM
Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
[TBL] [Abstract][Full Text] [Related]
18. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
Vilpo JA; Vilpo LM
Cancer Res; 1988 Jun; 48(11):3117-22. PubMed ID: 3163271
[TBL] [Abstract][Full Text] [Related]
19. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.
Bergerat JP; Drewinko B; Corry P; Barlogie B; Ho DH
Cancer Res; 1981 Jan; 41(1):25-30. PubMed ID: 7192598
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA.
Spiegelman S; Nayak R; Sawyer R; Stolfi R; Martin D
Cancer; 1980 Mar; 45(5 Suppl):1129-34. PubMed ID: 7357507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
